Promoters containing ATF-binding sites are de-regulated in cells that express the EWS/ATF1 oncogene.
about
Cyclin-dependent kinase 3-mediated activating transcription factor 1 phosphorylation enhances cell transformationIdentification of the receptor tyrosine kinase c-Met and its ligand, hepatocyte growth factor, as therapeutic targets in clear cell sarcomaRGG-boxes of the EWS oncoprotein repress a range of transcriptional activation domainsEstablishment of a novel clear cell sarcoma cell line (Hewga-CCS), and investigation of the antitumor effects of pazopanib on Hewga-CCS.Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformationMultiple aromatic side chains within a disordered structure are critical for transcription and transforming activity of EWS family oncoproteins.BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs.Molecular diagnosis of clear cell sarcoma: detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 casesThe melanocyte inducing factor MITF is stably expressed in cell lines from human clear cell sarcomaMolecular alterations in pediatric sarcomas: potential targets for immunotherapyA transcription assay for EWS oncoproteins in Xenopus oocytesPharmacologic suppression of MITF expression via HDAC inhibitors in the melanocyte lineageMolecular approaches to sarcoma therapy.EWS/ATF1 expression induces sarcomas from neural crest-derived cells in mice.The EWS-Oct-4 fusion gene encodes a transforming gene.Structure of noncoding RNA is a determinant of function of RNA binding proteins in transcriptional regulation.RGG boxes within the TET/FET family of RNA-binding proteins are functionally distinct.Differential interaction of PRMT1 with RGG-boxes of the FET family proteins EWS and TAF15.
P2860
Q24312766-765F7F6B-5CF9-4861-809F-84B311D96D50Q24645410-CF252EB9-BBF8-40A4-994E-80008B9C4315Q24798728-7AE9331B-03CF-49C9-985C-92127A91A94BQ33826472-39719A76-8A65-41FD-A1F7-315AA9090338Q34503194-A55AC4EF-4F67-4451-9506-8E7C10688153Q35578699-8607652D-1215-4413-BF62-E0371DDC0D6CQ35588657-EF1E0CA1-D2E1-4C57-8CDF-F86B2EADA20BQ35869365-436F6F4C-9BE9-4131-A45F-AF062FB42FF5Q36648458-BF923E93-47AD-4F06-A832-AD0E5FA3B6B4Q36673885-CB87C588-8A92-4182-95A6-7BF7D62D00C8Q36922599-7CA9DA8B-0143-408B-A590-91AC66BFA092Q37167249-3F4996CF-7D95-4D12-84B5-967D1B05B5C7Q37180948-A7509E8A-BA81-4AD1-906E-9CB72C8E014BQ39217770-078A5649-7481-429C-AF36-3E9EBA207F5EQ39253037-EDC95F34-526A-42C5-AD01-BE86D699F1F1Q40918849-8F92279E-1E3D-4172-B611-CB175DEECC88Q42356903-6E3A0DAD-B550-41B3-8110-17ACE95EA97FQ47343583-0FB29742-90C3-4620-BF2A-76F3C3C65C32
P2860
Promoters containing ATF-binding sites are de-regulated in cells that express the EWS/ATF1 oncogene.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Promoters containing ATF-bindi ...... express the EWS/ATF1 oncogene.
@en
type
label
Promoters containing ATF-bindi ...... express the EWS/ATF1 oncogene.
@en
prefLabel
Promoters containing ATF-bindi ...... express the EWS/ATF1 oncogene.
@en
P2093
P4510
P1433
P1476
Promoters containing ATF-bindi ...... express the EWS/ATF1 oncogene
@en
P2093
P304
P407
P577
1995-05-01T00:00:00Z